Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03888144 · ClinicalTrials.gov registry record · Phase 4
Study of Ketorolac Versus Opioid for Pain After Endoscopy
A Phase 4 study, sponsored by The Cleveland Clinic.
- Completed
- Registry status
- Phase 4
- Development phase
- 81
- Enrollment target
NCT03888144 is a Phase 4 study that has completed, run by The Cleveland Clinic. The registered enrollment target is 81 participants.
The verdict
NCT03888144, a Phase 4 study, has completed, sponsored by The Cleveland Clinic.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 81 participants
- Enrollment target
Study Summary
A double blind randomized controlled trial designed to compare pain control and safety with ketorolac and oxycodone in the post-operative setting for patients undergoing ureteroscopy for treatment of urinary stones. Patients are followed for five days after their surgery as they record their pain scores, medication utilization, and stent related symptoms.
Interventions
- DRUG Ketorolac
- DRUG Oxycodone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 81 participants |
| Start Date | 2017-10-13 |
| Est. Completion | 2021-08-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03888144
The ClinicalTrials.gov registry entry for NCT03888144 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 81 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Ketorolac is the first listed.
NCT03888144 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03888144 about?
NCT03888144 is a clinical study titled "Study of Ketorolac Versus Opioid for Pain After Endoscopy". A double blind randomized controlled trial designed to compare pain control and safety with ketorolac and oxycodone in the post-operative setting for patients undergoing ureteroscopy for treatment of urinary stones. Patients are followed for five days after their surgery as they record their pain sc...
What is the current status of trial NCT03888144?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 81 participants. The study started on 2017-10-13. Estimated completion is 2021-08-01.
What interventions are being tested in trial NCT03888144?
The interventions under investigation include: Ketorolac (DRUG), Oxycodone (DRUG).
Who is sponsoring clinical trial NCT03888144?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.